You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

Combination of carboplatin and chemotherapy improves outcomes for triple-negative breast cancer patients

December 11, 2014

In a clinical trial involving women with triple-negative breast cancer, patients who received the drugs carboplatin and/or bevacizumab in combination with standard chemotherapy prior to surgery were more likely to have their tumors disappear entirely from the breast, according to data presented by investigators during the 2014 San Antonio Breast Cancer Symposium.

Ian Krop, MD, PhD 

Dana-Farber presentations at SABCS 2014

Researchers and physicians from the Susan F. Smith Center for Women's Cancers presented research findings at this year's San Antonio Breast Cancer Symposium (SABCS), December 9 – 13. Read more about presentations by Dana-Farber oncologists.
 

Blocking a pathway causing hormonal therapy resistance may benefit women with advanced ER/PR-positive breast cancer
December 10, 2014

Adding a PI3K inhibitor to hormonal therapy for metastatic breast cancer may help overcome resistance to the hormonal therapy and delay disease progression, according to investigators from Dana-Farber Cancer Institute.

Common genetic variations may contribute to treatment-related cognitive problems in children with leukemia
December 09, 2014

Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia (ALL), according to research presented at the annual American Society of Hematology annual meeting in San Francisco.

Stem cell transplant without radiation or chemotherapy pre-treatment shows promise
December 07, 2014

Researchers report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant after pre-treatment with immunosuppressive drugs only. This is the first trial reporting successful transplant in dyskeratosis congenita (DC) patients without the use of any radiation or conventional cytotoxic chemotherapy beforehand.

Nivolumab Scores in Tough-to-Treat Hodgkin's Lymphoma (MedPageToday)

December 15, 2014

At the American Society of Hematology (ASH) annual meeting, Dr. Margaret Shipp and Dr. Philippe Armand presented their study finding 87 percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.

 

Adult survivors of childhood cancer get help with late effects of treatment (The Buffalo News)
December 15, 2014

Dr. Lisa Diller commented on the effects that childhood cancer treatment can have on adult survivors.

Long Radiation Treatments Called Unnecessary in Many Breast Cancer Cases (New York Times)
December 10, 2014

Dr. Harold Burstein commented on a study that found two-thirds of women who have lumpectomies for breast cancer are getting radiation treatment that lasts nearly twice as long as necessary.

Preliminary Studies Target Advanced Breast Cancers (WebMD)
December 10, 2014

Dr. Ian Krop presented results of a study on women with estrogen-receptor-positive cancer at the San Antonio Breast Cancer Symposium.

'Breakthrough' drug shows promise for ​Hodgkin lymphoma (CBS News)
December 08, 2014

At the American Society of Hematology (ASH) annual meeting, Dr. Margaret Shipp and Dr. Philippe Armand presented their study that found 87 percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.

Leukemia Therapy Shows Promise (The Wall Street Journal)
December 08, 2014

Dr. David Steensma commented on a drug, called AG-221, which targets a genetic mutation that prevents certain white blood cells from maturing into normal-functioning, infection-fighting cells, leading to acute myeloid leukemia and other blood cancers.

Cancer Drugs That Free Brake on Immune System Show Promise for Hodgkin’s (New York Times)
December 08, 2014

At the American Society of Hematology (ASH) annual meeting, Dr. Margaret Shipp and Dr. Philippe Armand presented their study that found 87 percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.

Kraft Family Blood Donor Center Blood Drive

December 19, 2014

9:00 AM - 3:00 PM

Linden Ponds

Linden Ponds
300 Linden Ponds Way, Hingham, MA 02043
VIEW MAP (https://goo.gl/maps/ZQ3uX)
Contact: Betty O'Reilly (781) 534-7234

more

Sunrise Qigong (NO CLASS)

December 19, 2014

Smith 330, Stoneman Patient Services Suite

 Presented by the Leonard P. Zakim Center for Integrative Therapies 

 
In this class, you will learn to stretch and strengthen your mind and body. 

 
Come relax, loosen and strengthen tired muscles, improve circulation, develop symmetry and balance and fine tune your mind/body skills. 

 
Program instructor, Ramel (Rami) Rones is on the leading edge of Mind-Body, Tai Chi and Qi Gong therapies for patients with cancer, fibromyalgia, arthritis, chronic pain and other chronic conditions. For adult patients, family members and caregivers. All levels welcome.


Registration required. For more information and to register, please contact the Zakim Center at 617-632-3322 or at Zakim_Center@dfci.harvard.edu.
 

more

Tai Chi for Optimal Health with Ramel Rones

December 19, 2014

11:30 AM - 1:00 PM

Smith Room, 330, Stoneman Patient Services Suite

An Internal Chinese martial art practiced for both defense training and health benefits. Learn sitting and standing techniques as well as slow moving meditation. Open to patients and family members. For more information or to register, please contact the Zakim Center at 617-632-3322 or Zakim_Center@dfci.harvard.edu. more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    For children:
    888-733-4662


    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button 
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2014-2015 logo    U.S. News Best Children's Hospitals Cancer 2014-2015 logo 

    Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer

  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now